Tirz

TIRZEPATIDE (TZ)

Tirzepatide is a dual GIP and GLP-1 receptor agonist that acts on pathways involved in appetite regulation, food intake, glucose control, and body weight.

Tirzepatide has been studied extensively for body-weight reduction and fat-loss-related outcomes, as well as metabolic and glucose regulation. In the U.S., tirzepatide is FDA-approved under specific brand names for chronic weight management and type 2 diabetes.

Product Details

• Tirzepatide (TZ)

• GIP / GLP-1 receptor activity

• Dual receptor agonist

• Fat-loss & metabolic research

• Investigational/research compound

SIMPLY SUPPLIES

PURE. RELIABLE. RESULTS.